Our Tenants

The oncology unit at QMB have developed a potent and flexible class of ADC payloads based on their proprietary PBD technology. PBD payloads have been clinically validated in multiple partnered programs.

They collaborate closely with licensors of the PBD ADC technology, providing expertise in the selection of the optimal payload for a particular application.